| The MR-Base platform supports systematic causal inference across the human phenome G Hemani, J Zheng, B Elsworth, KH Wade, V Haberland, D Baird, ... elife 7, e34408, 2018 | 5829 | 2018 |
| Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis SP Kar, PM Quiros, M Gu, T Jiang, J Mitchell, R Langdon, V Iyer, ... Nature Genetics 54 (8), 1155-1166, 2022 | 206 | 2022 |
| The EWAS Catalog: a database of epigenome-wide association studies T Battram, P Yousefi, G Crawford, C Prince, MS Babaei, G Sharp, ... Wellcome open research 7, 2022 | 184 | 2022 |
| Causal inference in cancer epidemiology: what is the role of Mendelian randomization? J Yarmolinsky, KH Wade, RC Richmond, RJ Langdon, CJ Bull, KM Tilling, ... Cancer Epidemiology, Biomarkers & Prevention 27 (9), 995-1010, 2018 | 158 | 2018 |
| DNA methylation-based predictors of health: applications and statistical considerations PD Yousefi, M Suderman, R Langdon, O Whitehurst, G Davey Smith, ... Nature Reviews Genetics 23 (6), 369-383, 2022 | 137 | 2022 |
| DNA methylation as a marker for prenatal smoke exposure in adults RC Richmond, M Suderman, R Langdon, CL Relton, G Davey Smith International journal of epidemiology 47 (4), 1120-1130, 2018 | 126 | 2018 |
| Circulating selenium and prostate cancer risk: a Mendelian randomization analysis J Yarmolinsky, C Bonilla, PC Haycock, RJQ Langdon, LA Lotta, ... JNCI: Journal of the National Cancer Institute 110 (9), 1035-1038, 2018 | 117 | 2018 |
| Influence of puberty timing on adiposity and cardiometabolic traits: a Mendelian randomisation study JA Bell, D Carslake, KH Wade, RC Richmond, RJ Langdon, EE Vincent, ... PLoS medicine 15 (8), e1002641, 2018 | 111 | 2018 |
| MR-Base: a platform for systematic causal inference across the phenome using billions of genetic associations G Hemani, J Zheng, KH Wade, C Laurin, B Elsworth, S Burgess, ... eLife Sciences Publications, Ltd, 2018 | 62 | 2018 |
| A phenome-wide Mendelian randomization study of pancreatic cancer using summary genetic data RJ Langdon, RC Richmond, G Hemani, J Zheng, KH Wade, ... Cancer Epidemiology, Biomarkers & Prevention 28 (12), 2070-2078, 2019 | 33 | 2019 |
| Clinical judgement by primary care physicians for the diagnosis of all‐cause dementia or cognitive impairment in symptomatic people ST Creavin, AH Noel-Storr, RJ Langdon, E Richard, AL Creavin, S Cullum, ... Cochrane Database of Systematic Reviews, 2022 | 32 | 2022 |
| Circulating adiponectin and leptin and risk of overall and aggressive prostate cancer: a systematic review and meta-analysis AJ Burton, R Gilbert, K Tilling, R Langdon, JL Donovan, JMP Holly, ... Scientific Reports 11 (1), 320, 2021 | 30 | 2021 |
| Epigenetic modelling of former, current and never smokers RJ Langdon, P Yousefi, CL Relton, MJ Suderman Clinical epigenetics 13, 1-13, 2021 | 25 | 2021 |
| Validation and characterisation of a DNA methylation alcohol biomarker across the life course PD Yousefi, R Richmond, R Langdon, A Ness, C Liu, D Levy, C Relton, ... Clinical epigenetics 11, 1-12, 2019 | 21 | 2019 |
| DNA methylation derived systemic inflammation indices are associated with head and neck cancer development and survival S Ambatipudi, R Langdon, RC Richmond, M Suderman, DC Koestler, ... Oral oncology 85, 87-94, 2018 | 20 | 2018 |
| MELODI: mining enriched literature objects to derive intermediates B Elsworth, K Dawe, EE Vincent, R Langdon, BM Lynch, RM Martin, ... International Journal of Epidemiology 47 (2), 369-379, 2018 | 20 | 2018 |
| Applying Mendelian randomization to appraise causality in relationships between nutrition and cancer KH Wade, J Yarmolinsky, E Giovannucci, SJ Lewis, IY Millwood, ... Cancer Causes & Control 33 (5), 631-652, 2022 | 19 | 2022 |
| Treatment preference and recruitment to pediatric RCTs: a systematic review L Beasant, A Brigden, RM Parslow, H Apperley, T Keep, A Northam, ... Contemporary Clinical Trials Communications 14, 100335, 2019 | 19 | 2019 |
| Epigenetic biomarkers of ageing are predictive of mortality risk in a longitudinal clinical cohort of individuals diagnosed with oropharyngeal cancer RA Beynon, SM Ingle, R Langdon, M May, A Ness, RM Martin, ... Clinical Epigenetics 14, 1-13, 2022 | 16 | 2022 |
| Identifying epigenetic biomarkers of established prognostic factors and survival in a clinical cohort of individuals with oropharyngeal cancer R Langdon, R Richmond, HR Elliott, T Dudding, N Kazmi, C Penfold, ... Clinical epigenetics 12, 1-19, 2020 | 14 | 2020 |
